ClinVar Miner

Submissions for variant NM_000075.4(CDK4):c.219-10C>T

gnomAD frequency: 0.00001  dbSNP: rs759302811
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000586402 SCV000695314 uncertain significance not provided 2017-02-23 criteria provided, single submitter clinical testing Variant summary: The CDK4 c.219-10C>T variant involves the alteration of a non-conserved intronic nucleotide. Mutation taster predicts a benign outcome for this variant along with 5/5 splice prediction tools predicting a benign impact on splicing. This variant was found in 1/121278 control chromosomes at a frequency of 0.0000082, which does not exceed the estimated maximal expected allele frequency of a pathogenic CDK4 variant (0.00002). The variant of interest has not, to our knowledge, been reported in affected individuals via publications and/or reputable databases/clinical diagnostic laboratories; nor evaluated for functional impact by in vivo/vitro studies. Of note, this variant was identified in a single specimen tested at our laboratory to co-occur with another "Likely Pathogenic" BRCA2 variant c.1648G>T (p.E550*), thus supporting a possible benign outcome. Because of the absence of clinical information and the lack of functional studies, the variant is classified as a variant of uncertain significance (VUS) until additional information becomes available.
Labcorp Genetics (formerly Invitae), Labcorp RCV001436444 SCV001639286 likely benign Familial melanoma 2025-01-02 criteria provided, single submitter clinical testing
Myriad Genetics, Inc. RCV004788000 SCV005404516 likely benign Melanoma, cutaneous malignant, susceptibility to, 3 2024-09-25 criteria provided, single submitter clinical testing This variant is considered likely benign. This variant is intronic and is not expected to impact mRNA splicing.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.